In under-resourced parts of Los Angeles, people develop life-altering, preventable diabetes complications related to obesity.

The two major party candidates provide ample reasons for pessimism about the future of the republic. If you're a fanatical ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

This list can have an impact on your drug coverage in 2025 and shows why this open enrollment is so important.

The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

Ozempic continues to grow in popularity in weight loss use. However, low-income patient populations who have an increased ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Almost 16% of American adults — or about 1 in 6 — have type 1 or type 2 diabetes, the US Centers for Disease Control and ...

Wegovy and Ozempic drove Novo Nordisk to record bumper sales since ... Biocon (which already has large-scale peptide ...